Skip to main content

Find Clinical Trials

Home
Conditions
Hamartoma

Clinical trial condition

Hamartoma

Explore clinical trials studying Hamartoma. Study availability and eligibility vary by location and protocol.

108 public trials 27 recruiting studies

Refine in advanced search Browse all conditions

Hamartoma trial results

Completed

Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

NCT00971789

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cowden's Disease, Genetic Diseases, Inborn, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

NCT00411619

Conditions: Astrocytoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +25 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances

NCT01903681

Conditions: Abnormalities, Multiple, Angelman Syndrome, Autism Spectrum Disorder, +27 more
Locations: Centre for Human Drug Research Leiden, Netherlands

View Trial Details

Completed

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

NCT00457964

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +27 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

NCT00792766

Conditions: Angiolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

NCT01031901

Conditions: Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
Locations: The University of Texas Health Science Center Houston, Texas, United States

View Trial Details

Completed

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

NCT00001869

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +29 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

NCT00457808

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Cincinnati Childrens Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Active, Not Recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819

Conditions: Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
Locations: Clinical Trial Site Little Rock, Arkansas, United States

Clinical Trial Site Downey, California, United States

Clinical Trial Site Long Beach, California, United States

Clinical Trial Site Sacramento, California, United States

View all 26 locations

View Trial Details

Active, Not Recruiting

MK-7075 (Miransertib) in Proteus Syndrome

NCT04316546

Conditions: Abnormalities, Multiple, Bone Diseases, Bone Diseases, Developmental, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details